Anti-diabetic and cardiac medicine prices decided
Picture for representative purpose (Photo: DC archives)
New Delhi: Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 108 non-scheduled formulation packs of 50 anti-diabetes and cardiac medicines.
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
( Source : dc correspondent )
Next Story
